Autres langues Sanofi India Limited NSE India S.E.

Actions

SANOFI

INE058A01010

Marché Fermé - NSE India S.E. Autres places de cotation 13:43:53 06/05/2024			Varia. 5j.	Varia. 1 janv.
8 539 ^INR	-0,99 %		+3,16 %	+5,84 %

15/04	Sanofi India Limited annonce la nomination de Flovie Martins au poste de responsable de la communication et de la responsabilité sociale de l'entreprise	CI
28/03	Sanofi India Limited annonce la démission de Marc-Antoine Lucchini en tant qu'administrateur non exécutif, membre du comité des nominations et des rémunérations	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Sanofi India Limited Announces Appointment of Flovie Martins as Head of Corporate Communications and Corporate Social Responsibility	15/04
Sanofi India Limited Announces Resignation of Marc-Antoine Lucchini as Non-Executive Director from the Board of Directors, Member of the Nomination and Remuneration Committee	28/03
Cipla to Distribute Sanofi's CNS Product Line in India	27/03
Sanofi India Limited, Sanofi Healthcare India Private Limited and Cipla Limited Announce an Exclusive Partnership	26/03
Sanofi India Limited and Emcure Pharmaceuticals Announces Exclusive Distribution Partnership to Broad Broadline Reach of Sanofi's Cardiovascular Brands	13/03
Sanofi India Limited Recommends Final Dividend for the Financial Year Ended 31St December 2023, Payable on or After 24 May 2024	23/02
Sanofi India Limited Declares Interim Dividend for the Financial Year Ended 31St December, 2023, Payable on or After 20 March, 2024	23/02
Sanofi India Limited Reports Earnings Results for the Full Year Ended December 31, 2023	23/02
Sanofi India Limited Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	23/02
Sanofi India Limited Appoints Radhika Shah as Head of Legal, Effective 15 January 2024	10/01
Sanofi India appoints Himanshu Bakshi as General Manager for its Consumer Healthcare business	20/12
Sanofi Sees Improvement in Trial Results of Cancer Drug Sarclisa	11/12
Trending : Merck's Multiple Sclerosis Drug Misses Expectations in Late-Stage Trials	06/12
Sanofi India's CFO Steps Down	09/11
Sanofi India Limited Announces the Resignation of Vaibhav Karandikar as Whole-Time Director	08/11
Sanofi India Limited Announces the Resignation of Vaibhav Karandikar as Chief Financial Officer, effective November 30, 2023	08/11
Sanofi India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	08/11
Sanofi India Limited Appoints Surabhi Kaul as India People Director and Will Be Part of the Senior Management Personnel	17/10/23
Sanofi India Limited Announces Executive Changes	26/09/23
Sanofi India Limited Announces Resignation of Vinita Korti Patil as Senior Legal Director - South Asia, Effective 7 December 2023	14/09/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Sanofi India Limited NSE India S.E.

Actions

SANOFI

INE058A01010

Autres langues

Filtres